Hanger Inc

Hanger — Hanger Orthopedic Group — Investor Presentation (August 2011)

30 slides from Hanger's investor presentation, Aug 5, 2011

  1. Slide 1: Investor Presentation August 2011: Advancing the Vision

    Investor Presentation August 2011 ADVANCING THE VISION

  2. Slide 2: Safe Harbor

    Except for the historical information contained herein, the matters discussed in this presentation constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These include the rate at which Hanger grows same-c

  3. Slide 3: Vision

    Be the partner of choice for products and services that enhance human physical capability. VISION 2

  4. Slide 4: Overview

    OVERVIEW Distribution Patient Care Therapeutics Solutions 11% of annualized revenues $99 million revenue 81% of annualized revenues Linkia 8% of annualized revenues ACP, Inc. IN, Inc. $732 million revenue $868 million in LTM revenues Adjusted EBITDA $136 million LTM 3 $65 Million Annualized revenue

  5. Slide 5: Disciplined Diversification of Revenue: Market

    DISCIPLINED DIVERSIFICATION OF REVENUE MARKET 4 Other Rehabilitation $1.1 billion market Post Acute Rehabilitation $0.2 billion market Traditional O&P $2.6 billion market

  6. Slide 6: Disciplined Diversification of Revenue: Hanger's Share

    DISCIPLINED DIVERSIFICATION OF REVENUE 5 HANGER’S SHARE 27% of Traditional O&P Market 30% of Post Acute Rehabilitation Market Other Rehabilitation $1.1 billion market Post Acute Rehabilitation $0.2 billion market Traditional O&P $2.6 billion market

  7. Slide 7: Compelling Growth Drivers

    COMPELLING GROWTH DRIVERS Sources: Company estimates; Wall Street Research; 2003–2006 National Health and Nutrition Examination Survey; National Institutes of Health; Amputee Coalition of America. Aging Population (U.S.) (%) Diabetes – Prevalence By Age Group Disease and aging population Advancing t

  8. Slide 8: Patient Care

    Hanger PATIENT CARE

  9. Slide 9: Patient Care Profile

    One or more certified practitioners Technical personnel Office administrators Line of site incentives to grow revenues and collect receivables CAGR up 7.7% (2007 -2010) PATIENT CARE PROFILE BUSINESS OVERVIEW CENTER OVERVIEW Over 675 O&P patient-care centers Over 1,100 O&P certified and licensed prac

  10. Slide 10: Patient Care Market Position

    PATIENT CARE MARKET POSITION Only national or regional provider Hanger operates ~25% of accredited O&P facilities No other provider has more than 2% market share Adjacent market of $1.4 Billion Principal Reimbursement Sources for Patient Care Services $2.6 Billion US Market 9

  11. Slide 11: Patient Care Growth Opportunities

    First to market with new technologies and products Linkia Network Management Diversification into new adjacent businesses CARES Dosteon Solutions Small O&P acquisitions Sales synergies with ACP PATIENT CARE GROWTH OPPORTUNITIES 10

  12. Slide 12: Linkia Network Management

    First and only O&P network management company Insurers’ exclusive or preferred provider of their network Hanger network of approximately 1,000 O&P centers 44 contracts; 1-3 years; auto renew Value proposition to large name companies through expanded services 28% CAGR of contracted revenues (2007-201

  13. Slide 13: Distribution

    7 ea DISTRIBUTION

  14. Slide 14: Distribution Profile

    Largest dedicated distributor of O&P devices and components Over 26,000 O&P related items 5 strategically located distribution facilities Comprehensive Customer Service Manufacture and distribute therapeutic footwear Net sales $99 million LTM and CAGR of 14% (2007-2010) Inter-company sales $178 mill

  15. Slide 15: Distribution Opportunities

    Increase depth and breadth of product line Increase penetration of existing customer base Expand customer base Expand market presence geographically Apply core competencies to adjacent businesses Expand O&P fabrication operation to Independent O&P Providers DISTRIBUTION OPPORTUNITIES 14

  16. Slide 16: Therapeutic Solutions

    ~ 900<Caa THERAPEUTIC SOLUTIONS

  17. Slide 17: Therapeutic Solutions: Diversification of Revenue

    Innovative Neurotronics Development and commercialization of products V-Hold and WalkAid Accelerated Care Plus (ACP) Value proposition to rehabilitation providers Technology, clinical modalities, training and education THERAPEUTIC SOLUTIONS— Diversification of Revenue 16

  18. Slide 18: ACP Overview

    17 ACP OVERVIEW ACP enables post-acute providers with 24 evidence-based clinical therapy programs Physical Agent Modality Basics Wound Healing Fall Prevention Continence Improvement Contracture Management Pain Management Physical Agent Modality Basics Osteoarthritis of the Knee Orthotic Therapy Hemi

  19. Slide 19: ACP Market Opportunities

    18 ACP MARKET OPPORTUNITIES ACP offers Hanger a $1.3 billion revenue post-acute opportunity Core SNF Business – $241 Million Opportunity Strong Core Business Recurring revenue business model with high customer retention Strong demographic trends Advancing new technologies, products and modalities co

  20. Slide 20: Financial Overview

    FINANCIAL OVERVIEW

  21. Slide 21: Solid Financial Position

    Earnings and margin growth Substantial cash flow generation Low maintenance capital expenditures Strong balance sheet management Moderate leverage post ACP acquisition SOLID FINANCIAL POSITION 20

  22. Slide 22: 2011 in Review

    22nd consecutive quarter of meeting or beating consensus earnings per share Same Store Sales 2.3% YTD and 4.1% for 2nd Quarter 20.8% growth in Adjusted EPS Improved Operating Margins Repriced Debt (March 2011) 2011 IN REVIEW 21

  23. Slide 23: Revenue Growth

    22 REVENUE GROWTH CAGR 8.6% ($ in millions)

  24. Slide 24: Adjusted EBITDA Growth and Margins

    23 ADJUSTED EBITDA GROWTH AND MARGINS* CAGR 13.3% * Excludes relocation expenses and cost related to the ACP acquisition. 13.2% 13.5% 14.1% Adjusted EBITDA (in millions) Adjusted EBITDA Margins % 14.9%

  25. Slide 25: Growth in Adjusted EPS

    24 GROWTH IN ADJUSTED EPS * Excludes relocation expenses, cost related to the ACP acquisition and accelerated non-cash preferred dividend in 2008. CAGR 30.4%

  26. Slide 26: Steady Comparable Quarter Growth

    STEADY COMPARABLE QUARTER GROWTH 2009 2010 2011 Adjusted EBITDA* ($ in millions) * Excludes relocation expenses and cost related to the ACP acquisition. Revenues ($ in millions) Adjusted Earnings Per Diluted Share* * Excludes relocation expenses, cost related to the ACP acquisition and accelerated n

  27. Slide 27: Improved Leverage & Liquidity

    IMPROVED LEVERAGE & LIQUIDITY 26 NOTE: Net Debt is Total Debt less Cash and Adjusted EBITDA adds back Restricted Stock and Deferred Compensation Non-Cash Expenses At 06/30/11 (millions) Cash and equivalents $ 19.50 Availability on Revolver $ 96.60 Total liquidity $ 116.10 Debt $ 506.10

  28. Slide 28: Days Sales Outstanding

    DAYS SALES OUTSTANDING

  29. Slide 29: Key Investment Points

    Compelling industry growth drivers Dominant market position Attractive organic growth opportunities Adjacent continuum of care opportunities Proven acquisition capabilities Solid financial position KEY INVESTMENT POINTS 28

  30. Slide 30: Hanger Orthopedic Group Inc.

    ORTHOPEDIC GROUP INC. anger Hager (NYSE: HGR) = SPS LINKIA Experience Our Commitment 0) ACP Sureitr CCleS Ovex: tetigual fy DOSTECN NEUROTRONICS

Hanger Orthopedic Group — Investor Presentation (August 2011) on 6ix